** Jefferies anticipates medium-term growth in healthcare service sector, propelled by increasing bulk billing and potential new incentives from the govt
** In FY25E, Jefferies continues to forecast market revenue growth of 10% in diagnostic imaging, 6% in pathology and 2.5% in assisted reproductive services on YOY basis
** Notes that despite recent decline in General Practitioner bulk-billing rates leading to lower clinical lab volumes, there's evidence of this trend reversing
** Maintains its forecasts for Healius HLS.AX, Integral Diagnostics IDX.AX, Monash IVF MVF.AX, and Sonic Healthcare SHL.AX
** Healthcare .AXHJ index down 8.1%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。